DNA mismatch repair gene polymorphisms affect survival in pancreatic cancer

Oncologist

Volumn 16, Issue 1, 2011, Pages 61-70

  Dong, Xiaoqun ^a   Li, Yanan ^a   Hess, Kenneth R ^a   Abbruzzese, James L ^a   Li, Donghui ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

DNA mismatch repair; Pancreatic cancer; Single nucleotide polymorphism; Survival

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; EXONUCLEASE I GENE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; METASTASIS; MISMATCH REPAIR; MUTL HOMOLOG 1 GENE; MUTS HOMOLOG 2 GENE; MUTS HOMOLOG 3 GENE; MUTS HOMOLOG 6 GENE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; POSTMEIOTIC SEGREGATION INCREASED 2 GENE; POSTMEIOTIC SEGREGATION INCREASED 2 LIKE 3 GENE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REQ PROTEIN LIKE DNA HELICASE Q1 LIKE GENE; SINGLE NUCLEOTIDE POLYMORPHISM; THREE PRIME REPAIR EXONUCLEASE 1 GENE; TUMOR PROTEIN 73 GENE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA MISMATCH REPAIR; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE;

EID: 79952604786     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-0127     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
2. Li D, Frazier M, Evans DB et al. Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. J Clin Oncol 2006;24:1720-1728.
3. Li D, Liu H, Jiao L et al. Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. Cancer Res 2006;66:3323-3330.
4. Dong X, Jiao L, Li Y et al. Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer. J Clin Oncol 2009;27:1592-1529.
5. Okazaki T, Javle M, Tanaka M et al. Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity. Clin Cancer Res 2010;16:320-329.
6. Jiricny J. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 2006;7:335-346.
7. Urist M, Tanaka T, Poyurovsky MV, et al. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes Dev 2004;18: 3041-3054.
8. Morgan MA, Parsels LA, Parsels JD et al. Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine. Cancer Res 2005; 65:6835-6842.
9. Constantin N, Dzantiev L, Kadyrov FA et al. Human mismatch repair: reconstitution of a nick-directed bidirectional reaction. J Biol Chem 2005; 280:39752-39761.
10. Nicolaides NC, Carter KC, Shell BK et al. Genomic organization of the human PMS2 gene family. Genomics 1995;30:195-206.
11. Zhang Y, Yuan F, Presnell SR et al. Reconstitution of 5_-directed human mismatch repair in a purified system. Cell 2005;122:693-705.
12. Yang YG, Lindahl T, Barnes DE. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 2007; 131:873-886.
13. Klapacz J, Meira LB, Luchetti DG et al. O6-methylguanine-induced cell death involves exonuclease 1 as well asDNAmismatch recognition in vivo. Proc Natl Acad Sci U S A 2009;106:576-581.
14. Kaina B, Christmann M, Naumann S et al. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair 2007;6:1079-1099.
15. Konduri SD, Ticku J, Bobustuc GC et al. Blockade of MGMT expression by O6 benzyl guanine leads to inhibition of pancreatic cancer growth and induction of apoptosis. Clin Cancer Res 2009;15:6087-6095.
16. Doherty KM, Sharma S, Uzdilla LA et al. RECQ1 helicase interacts with human mismatch repair factors that regulate genetic recombination. J Biol Chem 2005;280:28085-28094.
17. Sharma S, Stumpo DJ, Balajee AS et al. RECQL, a member of the RecQ family of DNA helicases, suppresses chromosomal instability. Mol Cell Biol 2007;27:1784-1794.
18. Stiewe T. The p53 family in differentiation and tumorigenesis. Nat Rev Cancer 2007;7:165-168.
19. Li LS, Morales JC, Hwang A et al. DNA mismatch repair-dependent activation of c-Abl/p73alpha/GADD45alpha-mediated apoptosis. J Biol Chem 2008;283:21394-21403.
20. Evans DB, Varadhachary GR, Crane CH et al. Preoperative gemcitabinebased chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol 2008;26:3496-3502.
21. Li D, Suzuki H, Liu B et al. DNA repair gene polymorphisms and risk of pancreatic cancer. Clin Cancer Res 2009;15:740-746.
22. Lee PH, Shatkay H. F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 2008;36:D820-D824.
23. Pounds S, Cheng C. Improving false discovery rate estimation. Bioinformatics 2004;20:1737-1745.
24. Jones S, Zhang X, Parsons DW et al. Core signaling pathways in humanpancreatic cancers revealed by global genomic analyses. Science 2008;321: 1801-1806.
25. Kastrinos F, Mukherjee B, Tayob N et al. Risk of pancreatic cancer in families with Lynch syndrome. JAMA 2009;302:1790-1795.
26. Luo Y, Lin FT, Lin WC. ATM-mediated stabilization of hMutL DNA mismatchrepair proteins augments p53 activation during DNA damage. Mol Cell Biol 2004;24:6430-6444.
27. Plaschke J, Kruger S, Jeske B et al. Loss of MSH3 protein expression is frequent in MLH1-deficient colorectal cancer and is associated with disease progression. Cancer Res 2004;64:864-870.
28. Melino G, De Laurenzi V, Vousden KH. p73: Friend or foe in tumorigenesis. Nat Rev Cancer 2002;2:605-615.
29. Lunghi P, Costanzo A, Mazzera L et al. The p53 family protein p73 providesnew insights into cancer chemosensitivity and targeting. Clin Cancer Res 2009;15: 6495-6502.
30. Khakhar RR, Cobb JA, Bjergbaek L et al. RecQ helicases: multiple roles in genome maintenance. Trends Cell Biol 2003;13:493-501.
31. Wu Y, Brosh RM Jr. Distinct roles of RECQ1 in the maintenance of genomic stability. DNA Repair 2010;9:315-324.
32. Gupta R, Brosh RM Jr. DNA repair helicases as targets for anti-cancer therapy. Curr Med Chem 2007;14:503-517.
33. Kimchi-Sarfaty C, Oh JM, Kim IW et al. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 2007;315:525-528.
34. Pickering BM, Willis AE. The implications of structured 5 ́ untranslated regions on translation and disease. Semin Cell Dev Biol 2005;16:39-47.
35. Mazumder B, Seshadri V, Fox PL. Translational control by the 3 ́ -UTR: the ends specify the means. Trends Biochem Sci 2003;28:91-98.